FBL and systemic sclerosis: In our study, we found that 31.1% of the SSc samples presented nucleolar pattern in the HEp-2 IFA test (some samples had additional overlapping patterns), and one third of the samples with nucleolar pattern (33.3%) were positive for anti-fibrillarin, representing 10.4% of the total SSc cohort.